Literature DB >> 15113888

Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis.

Minghao Sun1, Terri A Rothermel, Laurie Shuman, Jason A Aligo, Shibo Xu, Yuan Lin, Robert A Lamb, Biao He.   

Abstract

The paramyxovirus family includes many well-known human and animal pathogens as well as emerging viruses such as Hendra virus and Nipah virus. The V protein of simian virus 5 (SV5), a prototype of the paramyxoviruses, contains a cysteine-rich C-terminal domain which is conserved among all paramyxovirus V proteins. The V protein can block both interferon (IFN) signaling by causing degradation of STAT1 and IFN production by blocking IRF-3 nuclear import. Previously, it was reported that recombinant SV5 lacking the C terminus of the V protein (rSV5VDeltaC) induces a severe cytopathic effect (CPE) in tissue culture whereas wild-type (wt) SV5 infection does not induce CPE. In this study, the nature of the CPE and the mechanism of the induction of CPE were investigated. Through the use of DNA fragmentation, terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling, and propidium iodide staining assays, it was shown that rSV5VDeltaC induced apoptosis. Expression of wt V protein prevented apoptosis induced by rSV5VDeltaC, suggesting that the V protein has an antiapoptotic function. Interestingly, rSV5VDeltaC induced apoptosis in U3A cells (a STAT1-deficient cell line) and in the presence of neutralizing antibody against IFN, suggesting that the induction of apoptosis by rSV5VDeltaC was independent of IFN and IFN-signaling pathways. Apoptosis induced by rSV5VDeltaC was blocked by a general caspase inhibitor, Z-VAD-FMK, but not by specific inhibitors against caspases 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 13, suggesting that rSV5VDeltaC-induced apoptosis can occur in a caspase 12-dependent manner. Endoplasmic reticulum stress can lead to activation of caspase 12; compared to the results seen with mock and wt SV5 infection, rSV5VDeltaC infection induced ER stress, as demonstrated by increased expression levels of known ER stress indicators GRP 78, GRP 94, and GADD153. These data suggest that rSV5VDeltaC can trigger cell death by inducing ER stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113888      PMCID: PMC400337          DOI: 10.1128/jvi.78.10.5068-5078.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  To kill or be killed: viral evasion of apoptosis.

Authors:  Chris A Benedict; Paula S Norris; Carl F Ware
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 2.  The Bcl2 family: regulators of the cellular life-or-death switch.

Authors:  Suzanne Cory; Jerry M Adams
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

3.  Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-converting enzyme gene expression but does not cause apoptosis.

Authors:  R Takeuchi; H Tsutsumi; M Osaki; K Haseyama; N Mizue; S Chiba
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling.

Authors:  Biao He; Reay G Paterson; Nicola Stock; Joan E Durbin; Russell K Durbin; Stephen Goodbourn; Richard E Randall; Robert A Lamb
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

5.  The RNA binding region of the paramyxovirus SV5 V and P proteins.

Authors:  G Y Lin; R G Paterson; R A Lamb
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

6.  Recovery of infectious SV5 from cloned DNA and expression of a foreign gene.

Authors:  B He; R G Paterson; C D Ward; R A Lamb
Journal:  Virology       Date:  1997-10-27       Impact factor: 3.616

7.  A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.

Authors:  N A Thornberry; T A Rano; E P Peterson; D M Rasper; T Timkey; M Garcia-Calvo; V M Houtzager; P A Nordstrom; S Roy; J P Vaillancourt; K T Chapman; D W Nicholson
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

8.  Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death.

Authors:  Elizabeth K Wansley; Griffith D Parks
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells.

Authors:  Robert Jordan; Lijuan Wang; Thomas M Graczyk; Timothy M Block; Patrick R Romano
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Human caspase 12 has acquired deleterious mutations.

Authors:  Heinz Fischer; Ulrich Koenig; Leopold Eckhart; Erwin Tschachler
Journal:  Biochem Biophys Res Commun       Date:  2002-05-03       Impact factor: 3.575

View more
  33 in total

1.  Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Authors:  S Mark Tompkins; Yuan Lin; George P Leser; Kari A Kramer; Debra L Haas; Elizabeth W Howerth; Jie Xu; Mary J Kennett; Russell K Durbin; Joan E Durbin; Ralph Tripp; Robert A Lamb; Biao He
Journal:  Virology       Date:  2007-01-23       Impact factor: 3.616

2.  Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice.

Authors:  Zhuo Li; Jon D Gabbard; Alaina Mooney; Zhenhai Chen; S Mark Tompkins; Biao He
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

3.  Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.

Authors:  Liqun Zhang; Peter L Collins; Robert A Lamb; Raymond J Pickles
Journal:  Virology       Date:  2011-10-08       Impact factor: 3.616

4.  Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Yasuhiko Ito
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.

Authors:  Maria D Gainey; Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses.

Authors:  Minghao Sun; Sandra M Fuentes; Khalid Timani; Dengyun Sun; Chris Murphy; Yuan Lin; Avery August; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.

Authors:  Nora H Rosas-Murrieta; Irma Herrera-Camacho; Helen Palma-Ocampo; Gerardo Santos-López; Julio Reyes-Leyva
Journal:  Virol J       Date:  2010-10-11       Impact factor: 4.099

8.  Canine distemper virus selectively inhibits apoptosis progression in infected immune cells.

Authors:  Stéphane Pillet; Veronika von Messling
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

Review 9.  Reverse genetics approaches to combat pathogenic arenaviruses.

Authors:  Juan C de la Torre
Journal:  Antiviral Res       Date:  2008-09-07       Impact factor: 5.970

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.